Guideline-based rapid initiation of antiretroviral therapy (ART) for treatment of human immunodeficiency virus (HIV) is now the standard of care. ¹Best-practice rapid ART protocols promote immediate linkage to HIV care, decreased time to ART initiation, decreased time to viral suppression (VS), and long-term VS — even within vulnerable populations. ²Shorter time to VS is associated with decreases in the incidence of both AIDS- and non-AIDS–related events. ³It further benefits the individual’s partners and at-risk populations by decreasing the period of time during which the virus is transmittable. This informs the Undetectable Equals Untransmittable (U=U) initiative, which serves not only the public health goal of ending the HIV/AIDS pandemic, but also brings equity to HIV care for vulnerable populations. ⁴Geared to the needs of HIV-specialist clinicians, this HIV Experts and Evidence™ meeting series will address rapid ART guidelines, provide practical solutions to systemic and clinical barriers that can impede access to rapid ART regimens and retention in care, and real-world approaches to enhanced patient-centered services.
- U.S. Department of Health and Human Services. Guidelines for Use of Antiretroviral Agents in HIV-1−Infected Adults and Adolescents Living with HIV. Last updated July 2020. https://aidsinfo.nih.gov/guidelines. Accessed August 24, 2020.
- Coffey S, et al. RAPID antiretroviral therapy: high virologic suppression rates with immediate ART initiation in a vulnerable urban clinic population AIDS. 2019;33(5):825-832.
- The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795-807.
- Eisinger RW, et al. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451-452.
Getting to Zero: Ending the HIV Epidemic
Early, Sustained Viral Suppression A - Key Disease-Management and Prevention Strategy
Rapid Antiretroviral Therapy (ART) Initiation: Operationalizing Early Viral Suppression
Addressing Barriers to Rapid Start
Manage This Patient: An Interactive Case-Based Activity
Concluding Comments: Will Rapid ART initiation be your established standard of care in one year?
This activity is intended for infectious diseases and HIV– specialist physicians and other clinicians and stakeholders involved in the care of patients with HIV infection.
After completing this activity, the participant should be better able to:
- Reduce time from HIV diagnosis to viral suppression to improve patient outcomes and prevent HIV transmission
- Select appropriate regimens for rapid ART initiation based on current guidelines and patient characteristics
- Implement strategies designed to decrease barriers to the provision of rapid ART to patients with newly diagnosed HIV infection
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates each activity in this live series for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-20-106-L02-P).
This is a knowledge-based activity.
Instructions to Receive Credit
To receive credit for this activity, submit a completed activity posttest and evaluation form at the conclusion of the program. You will be emailed a certificate within 3 weeks. If you do not receive your credit at that time, please contact email@example.com. For ACPE learners, please check the CPE monitor for your CE credit within 60 days of the activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Christa Master prior to the live event at firstname.lastname@example.org.
There is no fee for this educational activity
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
Integritas Communications Contact Information
For other questions about this meeting series, please contact Christa Master at firstname.lastname@example.org.
This meeting series is jointly provided by Global Education Group and Integritas Communications.
This meeting series is supported by an independent educational grant from Gilead Sciences, Inc.
We would like to thank the American Academy of HIV Medicine (AAHIVM) for their collaboration and support.